COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator
By MDS C19 staff , November 20 2020
With a fast-moving pandemic, no one is safe, unless everyone is safe
The vaccines pillar of the ACT-Accelerator, convened by CEPI GAVI and WHO, is speeding up the search for an effective vaccine for all countries. At the same time, it is supporting the building of manufacturing capabilities, and buying supply, ahead of time so that 2 billion doses can be fairly distributed by the end of 2021.
Developing a vaccine against COVID-19 is the most pressing challenge of our time – and nobody wins the race until everyone wins.
The global pandemic has already caused the loss of hundreds of thousands of lives and disrupted the lives of billions more. As well as reducing the tragic loss of life and helping to get the pandemic under control, introduction of a vaccine will prevent the loss of US$ 375 billion to the global economy every month. Global equitable access to a vaccine, particularly protecting health care workers and those most-at-risk is the only way to mitigate the public health and economic impact of the pandemic.
Doses for at least 20% of countries' populations
Diverse and actively managed portfolio of vaccines
Vaccines delivered as soon as they are available
End the acute phase of the pandemic